distribution of remote monitoring and resuscitation solutions for pre-hospital and critical care services.

Philips therapeutic care business leader Arman Voskerchyan said: “We are committed to investing in and expanding our resuscitation and emergency care offering, and with the acquisition of RDT we can boost our capabilities and portfolio in this vital area of healthcare.”

Established in 1997, RDT provides advanced monitoring, cardiac therapy and data management solutions to its customers.

The firm’s connected emergency care solutions are said to complement Philips’ therapeutic care business and strengthen its presence in the €1.4bn resuscitation and emergency care market.

Currently, Philips produces a range of monitoring and therapeutic products and solutions, including automated external defibrillators (AEDs), advanced life support monitors and data management solutions.

RDT produces Tempus ALS modularized monitor and defibrillator, Tempus Pro advanced critical care monitor and Tempus LS professional defibrillator

The firm also provides lightweight monitors installed with telecommunication capabilities for various emergency responders.

With around 100 employees, RDT carries out operations in Europe and North America.

RDT CEO Graham Murphy said: “Our mission is very much aligned with Philips’ own, as we are committed to transforming the delivery of care and improving patient outcomes driven by customer-focused innovation.”

In May this year, Philips acquired Netherlands-based digital health scale-up company, NightBalance, for an undisclosed sum.

NightBalance has developed a device for the treatment of positional obstructive sleep apnea and positional snoring.

The company’s sleep position trainer (SPT) has been designed to serve as an easy to use treatment alternative for people suffering from positional obstructive sleep apnea.

Philips offers a range of care solutions for people with obstructive sleep apnea, including DreamWear, DreamStation and DreamMapper.